{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:30:00Z","timestamp":1792783800527,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"10-11","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ningbo Medical Technology Project","award":["2004050"],"award-info":[{"award-number":["2004050"]}]},{"name":"Natural Science Foundation of Ningbo","award":["2009A610186"],"award-info":[{"award-number":["2009A610186"]}]},{"name":"Scientific Research Fund of Ningbo Technology Innovation Team","award":["2009B21002"],"award-info":[{"award-number":["2009B21002"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.clinbiochem.2012.04.016","type":"journal-article","created":{"date-parts":[[2012,4,28]],"date-time":"2012-04-28T13:56:30Z","timestamp":1335621390000},"page":"787-792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Impact of catechol-o-methyltransferase polymorphisms on risperidone treatment for schizophrenia and its potential clinical significance"],"prefix":"10.1016","volume":"45","author":[{"given":"Shugui","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuguang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaizhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minfang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/schbul\/19.1.85","article-title":"A theory of dopamine function and its role in cognitive deficits in schizophrenia","volume":"19","author":"Cohen","year":"1993","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0024-3205(97)00228-2","article-title":"Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications","volume":"61","author":"Carlsson","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00008571-199606000-00007","article-title":"Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders","volume":"6","author":"Lachman","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0020","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrn2841","article-title":"22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia","volume":"11","author":"Karayiorgou","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0025","first-page":"270","article-title":"Catechol-O-methyl transferase and schizophrenia","volume":"22","author":"Sagud","year":"2010","journal-title":"Psychiatr Danub"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0030","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1073\/pnas.111134598","article-title":"Effect of COMT Val108\/158 Met genotype on frontal lobe function and risk for schizophrenia","volume":"98","author":"Egan","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0035","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/schbul\/sbm019","article-title":"Is COMT a susceptibility gene for schizophrenia?","volume":"33","author":"Williams","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biopsych.2009.08.039","article-title":"Catechol-o-methyltransferase valine(158)methionine genotype and resting regional cerebral blood flow in medication-free patients with schizophrenia","volume":"67","author":"Eisenberg","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0045","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1523\/JNEUROSCI.1792-04.2005","article-title":"Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex","volume":"25","author":"Smolka","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-008-1381-7","article-title":"The catechol-O-methyltransferase Val(108\/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting","volume":"203","author":"Benedetti","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0055","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1176\/ajp.161.10.1798","article-title":"Interaction of COMT Val108\/158Met genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia","volume":"161","author":"Bertolino","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.schres.2006.10.002","article-title":"COMT val108\/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia","volume":"90","author":"Woodward","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0065","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.tpj.6500211","article-title":"Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone","volume":"3","author":"Yamanouchi","year":"2003","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/hup.841","article-title":"Catechol-O-methyltransferase val108\/158met genotype and response to antipsychotic medication in schizophrenia","volume":"22","author":"Illi","year":"2007","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpsychires.2005.03.005","article-title":"Chronic antipsychotics treatment regulates MAOA, MAOB and COMT gene expression in rat frontal cortex","volume":"41","author":"Chen","year":"2007","journal-title":"J Psychiatr Res"},{"issue":"4","key":"10.1016\/j.clinbiochem.2012.04.016_bb0080","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0987-7053(00)00224-0","article-title":"The p300 cognitive event-related potential. II. Individual variability and clinical application in psychopathology","volume":"30","author":"Hansenne","year":"2000","journal-title":"Neurophysiol Clin"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.04.016_bb0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1469-8986.1997.tb02415.x","article-title":"P300 event\u2010related potential heritability in monozygotic and dizygotic twins","volume":"34","author":"Katsanis","year":"1997","journal-title":"Psychophysiology"},{"issue":"6","key":"10.1016\/j.clinbiochem.2012.04.016_bb0090","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10519-006-9091-6","article-title":"Heritability and reliability of P300, P50 and duration mismatch negativity","volume":"36","author":"Hall","year":"2006","journal-title":"Behav Genet"},{"issue":"3","key":"10.1016\/j.clinbiochem.2012.04.016_bb0095","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.psychres.2008.06.035","article-title":"The P300 as a possible endophenotype for schizophrenia and bipolar disorder: evidence from twin and patient studies","volume":"169","author":"Bestelmeyer","year":"2009","journal-title":"Psychiatry Res"},{"issue":"2\u20133","key":"10.1016\/j.clinbiochem.2012.04.016_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.psychres.2008.07.008","article-title":"Association study of catechol-O-methyltransferase (COMT) gene Val158Met polymorphism with auditory P300 in Chinese Han patients with schizophrenia","volume":"180","author":"Kang","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0105","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4088\/JCP.v64n1113","article-title":"Prolactin levels during long-term risperidone treatment in children and adolescents","volume":"64","author":"Findling","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0110","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0149-2918(00)80086-7","article-title":"The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia","volume":"22","author":"David","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2217\/14622416.10.3.385","article-title":"Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment","volume":"10","author":"Gupta","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.psychres.2009.03.029","article-title":"Analysis of association between the catechol-O-methyltransferase (COMT) gene and negative symptoms in chronic schizophrenia","volume":"179","author":"Wang","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0125","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1176\/appi.ajp.2009.08081251","article-title":"Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children","volume":"166","author":"Barnett","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.biopsych.2008.09.027","article-title":"Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia","volume":"65","author":"Prata","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biopsych.2008.01.005","article-title":"Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158\/108Met polymorphism","volume":"64","author":"Barnett","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0140","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.schbul.a033376","article-title":"The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia","volume":"25","author":"Meltzer","year":"1999","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0145","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.4088\/JCP.v68n0804","article-title":"Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study","volume":"68","author":"Harvey","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0150","doi-asserted-by":"crossref","first-page":"8709","DOI":"10.1523\/JNEUROSCI.2077-08.2008","article-title":"Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice","volume":"28","author":"Papaleo","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0155","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.60.7.681","article-title":"Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder","volume":"60","author":"Potkin","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0160","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.pnpbp.2008.05.006","article-title":"Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients","volume":"32","author":"Yasui-Furukori","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.clinbiochem.2012.04.016_bb0165","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0920-9964(98)00159-5","article-title":"Neuroleptic-induced hyperprolactinemia","volume":"35","author":"Dickson","year":"1999","journal-title":"Schizophr Res"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012002019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012002019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:37:24Z","timestamp":1757864244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912012002019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":33,"journal-issue":{"issue":"10-11","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0009912012002019"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.04.016","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of catechol-o-methyltransferase polymorphisms on risperidone treatment for schizophrenia and its potential clinical significance","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}